Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Conditions: Acute Myeloid Leukemia Interventions: Drug: Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;; Drug: Venetoclax (Venetoclax): 400mg on day 1 to day 7; oral administration;; Other: utologous stem cell transplantation (ASCT) /allogeneic hematopoietic stem cell transplantation (allo-HSCT). Sponsors: The First Affiliated Hospital with Nanjing Medical University; Huai ' an First People ' s Hospital; Yancheng First People ' s Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials